ADC Bio completed construction of a £5 million bioconjugation cleanroom in July of 2019. Located within the company's 70,000-sf facility in Deeside in the United Kingdom, the GMP lab will support the commercial manufacture of innovative antibody-drug conjugates for the treatment of cancer. Designed and constructed by WHP Engineering, the project houses Grade C and D cleanrooms with four-zone HVAC systems for optimal environmental containment. WHP provided testing and validation services for the facility, which includes labs for quality, control, and process development, as well as support areas for washing, depyrogenation, thawing, and buffer preparation. The project features a customized toxic waste system that removes effluent to a holding tank for transport to an offsite incinerator, with dry-break couplers on both pipeline ends to prevent contamination.
